IRADIMED CORPORATION
$92.93
▼
-0.32%
2026-04-21 07:35:01
www.iradimed.com
NGM: IRMD
Explore IRADIMED CORPORATION stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.19 B
Current Price
$92.93
52W High / Low
$107.9 / $50
Stock P/E
52.96
Book Value
$7.4
Dividend Yield
0.76%
ROCE
26.52%
ROE
24.78%
Face Value
—
EPS
$1.75
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
166
Beta
1.12
Debt / Equity
0
Current Ratio
7.98
Quick Ratio
6.84
Forward P/E
40.26
Price / Sales
14.24
Enterprise Value
$1.14 B
EV / EBITDA
41.84
EV / Revenue
13.63
Rating
Strong Buy
Target Price
$118.67
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Meaningful dividend yield is available.
Cons
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
| 2. | InfuSystem Holdings, Inc. | $10.79 | 32.21 | $213.43 M | — | 14.83% | 11.54% | $11.04 / $4.66 | $2.84 |
| 3. | TELA Bio, Inc. | $0.63 | — | $30.55 M | — | -53.21% | -2.23% | $2.2 / $0.5 | $0.14 |
| 4. | Zimmer Biomet Holdings, Inc. | $94.32 | 26.61 | $18.29 B | 1.04% | 6.61% | 5.6% | $108.29 / $84.59 | $64.95 |
| 5. | Standard BioTools Inc. | $0.97 | — | $361.83 M | — | -20.31% | -13.13% | $1.72 / $0.87 | $1.23 |
| 6. | Tenon Medical, Inc. | $0.8 | — | $9.06 M | — | -169.5% | -2.28% | $2.48 / $0.64 | $0.18 |
| 7. | Penumbra, Inc. | $333.46 | 73.7 | $13.1 B | — | 11.52% | 13.78% | $362.41 / $221.26 | $36.39 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 22.69 M | 21.2 M | 20.41 M | 19.51 M | 19.39 M | — |
| Operating Profit | 7.09 M | 6.83 M | 6.79 M | 5.43 M | 5.8 M | — |
| Net Profit | 6.44 M | 5.58 M | 5.77 M | 4.69 M | 5.15 M | — |
| EPS in Rs | 0.5 | 0.44 | 0.45 | 0.37 | 0.4 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 83.81 M | 73.24 M | 65.56 M | 53.3 M |
| Operating Profit | 26.15 M | 21.96 M | 20.04 M | 15.63 M |
| Net Profit | 22.48 M | 19.23 M | 17.19 M | 12.83 M |
| EPS in Rs | 1.76 | 1.5 | 1.35 | 1 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 108.78 M | 98.33 M | 92.16 M | 85.51 M |
| Total Liabilities | 14.16 M | 11.51 M | 20.74 M | 11.84 M |
| Equity | 94.62 M | 86.82 M | 71.42 M | 73.67 M |
| Current Assets | 81.2 M | 75.24 M | 76 M | 77.49 M |
| Current Liabilities | 10.18 M | 8.51 M | 16.33 M | 8.55 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 24.95 M | 25.62 M | 13.47 M | 10.04 M |
| Investing CF | -8.42 M | -8.82 M | -8.01 M | -1.37 M |
| Financing CF | -17.6 M | -14.34 M | -13.66 M | -12.71 M |
| Free CF | 16.53 M | 16.81 M | 5.46 M | 8.17 M |
| Capex | -8.42 M | -8.82 M | -8.01 M | -1.87 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11.71% | 23% | — | — |
| Earnings Growth % | 11.87% | 34.02% | — | — |
| Profit Margin % | 26.26% | 26.22% | 24.07% | — |
| Operating Margin % | 29.99% | 30.56% | 29.32% | — |
| Gross Margin % | 76.94% | 76.5% | 77.45% | — |
| EBITDA Margin % | 31.11% | 31.73% | 30.58% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-02-23 | $0.2 |
| 2025-12-17 | $0.5 |
| 2025-11-14 | $0.17 |
| 2025-08-18 | $0.17 |
| 2025-05-20 | $0.17 |
Stock Splits
No stock split history available.